The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors.
Farren, Matthew R
The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors. [electronic resource] - Molecular cancer therapeutics 03 2017 - 417-427 p. digital
Publication Type: Journal Article
1538-8514
10.1158/1535-7163.MCT-16-0498 doi
Animals
Antibodies, Monoclonal--pharmacology
Antineoplastic Agents--pharmacology
B7-H1 Antigen--antagonists & inhibitors
CTLA-4 Antigen--antagonists & inhibitors
Cell Line, Tumor
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Synergism
Humans
Hydrazines--pharmacology
Immunomodulation--drug effects
Karyopherins--antagonists & inhibitors
Melanoma, Experimental
Mice
Neoplasms--drug therapy
Receptors, Cytoplasmic and Nuclear--antagonists & inhibitors
T-Lymphocytes--drug effects
Triazoles--pharmacology
Exportin 1 Protein
The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors. [electronic resource] - Molecular cancer therapeutics 03 2017 - 417-427 p. digital
Publication Type: Journal Article
1538-8514
10.1158/1535-7163.MCT-16-0498 doi
Animals
Antibodies, Monoclonal--pharmacology
Antineoplastic Agents--pharmacology
B7-H1 Antigen--antagonists & inhibitors
CTLA-4 Antigen--antagonists & inhibitors
Cell Line, Tumor
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Synergism
Humans
Hydrazines--pharmacology
Immunomodulation--drug effects
Karyopherins--antagonists & inhibitors
Melanoma, Experimental
Mice
Neoplasms--drug therapy
Receptors, Cytoplasmic and Nuclear--antagonists & inhibitors
T-Lymphocytes--drug effects
Triazoles--pharmacology
Exportin 1 Protein